# EDGAR Filing Document

**Accession Number:** 0001078799
**File Stem:** 0001079973-23-000170
**Filing Date:** 2023-2
**Character Count:** 5150
**Document Hash:** 96e2195c84c7ff6d30ac14463ad16759
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001079973-23-000170.hdr.sgml**: 20230208

**ACCESSION NUMBER**: 0001079973-23-000170

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 12

**CONFORMED PERIOD OF REPORT**: 20230208

**ITEM INFORMATION**: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

**FILED AS OF DATE**: 20230208

**DATE AS OF CHANGE**: 20230208

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Marijuana Co of America, Inc.
- **CENTRAL INDEX KEY:** 0001078799
- **STANDARD INDUSTRIAL CLASSIFICATION:** MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
- **IRS NUMBER:** 870426858
- **STATE OF INCORPORATION:** UT
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-27039
- **FILM NUMBER:** 23599712

**BUSINESS ADDRESS:**
- **STREET 1:** 633 W. 5TH STREET
- **STREET 2:** SUITE 2826
- **CITY:** LOS ANGELES
- **STATE:** CA
- **ZIP:** 90071
- **BUSINESS PHONE:** (888) 777-4362

**MAIL ADDRESS:**
- **STREET 1:** 633 W. 5TH STREET
- **STREET 2:** SUITE 2826
- **CITY:** LOS ANGELES
- **STATE:** CA
- **ZIP:** 90071

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CONVERGE GLOBAL INC/CA
- **DATE OF NAME CHANGE:** 19990806

?xml version="1.0" encoding="utf-8"?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

**Date of Report (Date of earliest event reported): February 8, 2023**

**MARIJUANA COMPANY OF AMERICA, INC.**

(Exact Name of Registrant as Specified in Charter)

---

| | | |
|:---|:---|:---|
| **<u>Utah</u>** | **<u>000-27039</u>** | **<u>98-1246221</u>** |
| (State or jurisdiction of | (Commission File | (IRS Employer |
| incorporation or organization) | Number) | Identification No.) |

---

**633 W. 5th Street, Suite 2826**

**Los Angeles, California ,90071**

**<u>Telephone: (888) 777-4362</u>**

(Address and Telephone Number of Registrant's Principal

Executive Offices and Principal Place of Business)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425).

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12).

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)).

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)).

Securities registered pursuant to Section 12(b) of the Act: None.

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒

Securities registered pursuant to Section 12(g) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Common Stock | MCOA | None |

---

**Section 5 - Corporate Governance and Management** 

**Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers**

On February 8, 2023, Tad Mailander resigned as an independent director of the Company. The company provided Mr. Mailander with a copy of the disclosures made in this Form 8-K before filing and informed Mr. Mailander of the opportunity to furnish a letter addressed to the company as promptly as possible stating whether he agrees with the company's disclosures in response to this item and, if not, stating the disagreements. The company will file any letter it receives from Mr. Mailander as an exhibit by amendment to the previously filed Form 8-K within two business days after receipt by the company.

**Item 9.01. Financial Statements and Exhibits.**

---

| | |
|:---|:---|
| **Exhibit Number** | **Description** |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). |

---

**SIGNATURES**

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | |
|:---|:---|
|  | **MARIJUANA COMPANY OF AMERICA, INC.**<br>|
|  | By: <u>*/s/ Jesus M. Quintero*&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u> |
| Date: February 8, 2023 | Name: Jesus M. Quintero<br> Title: Chief Executive Officer |

---